|
WO2020166974A1
|
|
Method for monitoring whether drug passes through blood-brain barrier by using brain tissue clearing
|
|
KR20210007496A
|
|
Brain tissue clearing composition and Method for evaluating synaptic dysfunction using the same
|
|
EP3778920A1
|
|
Method for three-dimensional nucleic acid imaging diagnosis of bio-tissue by using isothermal nucleic acid amplification
|
|
KR20200095881A
|
|
Method for evaluating synaptic dysfunction using brain tissue clearing
|
|
KR20200095882A
|
|
Method for evaluating angiogenesis in cancer tissue using tissue clearing
|
|
KR20200022989A
|
|
Pressure device for enhancing of tissue clearing and antibody penetration using nitrogen gas
|
|
KR20200019024A
|
|
Immunohistochemistry enhancer kit for enhancing antibody penetration into a biological tissue
|
